An update on medical therapy for pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

An update on medical therapy for pulmonary arterial hypertension.

An update on medical therapy for pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q38152292

about

Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series)Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.New pharmacotherapies for pulmonary hypertension: where do they fit in?A randomized double blinded placebo controlled trial of sildenafil for renoprotection prior to hilar clamping in patients undergoing robotic assisted laparoscopic partial nephrectomy.Macitentan: An important addition to the treatment of pulmonary arterial hypertension.Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition.Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases.

P2860

Q28082797-AD8F77E9-15A2-479A-8064-43B3B547349E Q28084598-8E2F7125-0D6F-44F4-BBE4-CAA64E0FC1DF Q34270071-988D111E-53D9-4282-8533-B53FE59121F4 Q36239561-60158295-DD1F-46DE-8C16-73E96CDAF688 Q38258961-F5EBB93B-D40D-43DF-A18A-D261F3FB87B7 Q38950658-37F7EA47-90C5-44BB-B7F4-91444D316F6A Q40259209-50896CE0-1537-4E05-B179-AF8F2604261F Q43055099-F38EA828-AB56-4F27-ACCF-41CF23973CBE Q43184339-1EC10F89-9B22-480D-8274-EDC49F1A0809

P2860

An update on medical therapy for pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q38152292

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

An update on medical therapy for pulmonary arterial hypertension.

@en

type

label

An update on medical therapy for pulmonary arterial hypertension.

@en

prefLabel

An update on medical therapy for pulmonary arterial hypertension.

@en

P1433

Q38152292-173A512A-FF39-41FF-96D1-A869EFD7509E

P1476

Q38152292-91EC0CA4-EE36-427F-8E43-BC659E95F237

P2093

Q38152292-B684952E-AEFC-4A42-87E1-67AD16780FF4

P2860

Q38152292-03DCB1AF-8D24-40C6-83C8-20DF96A0C50E

Q38152292-04197DAC-0462-4E15-9F20-2EA0137ADA65

Q38152292-044053EB-4D70-4BFB-8A1A-822B6488F6A5

Q38152292-05EC785C-319E-4A60-920F-7863BDA47C3A

Q38152292-063343F4-7772-4747-B371-C1CD3B1DD2E8

Q38152292-06724BEB-4757-440A-B49A-21C6ED675257

Q38152292-0B129860-6736-492C-8BE7-95668283930A

Q38152292-0E966355-05CE-4A25-A8B7-166D715589FF

Q38152292-0EBA7563-DDA5-45A1-960C-0D630E779764

Q38152292-10F158FA-75D5-4863-96A5-ADB563139BCF

P2888

Q38152292-9D7F6BA2-E3F6-4171-AD59-420F4E57E641

P304

Q38152292-E6E901A0-A78E-4F96-A418-55EC2B25C8A9

P31

Q38152292-91605177-7612-434F-B391-FDFB8DFB7996

P356

Q38152292-17D70D17-E7EF-49D6-B0F7-13A0E6F181C7

P433

Q38152292-BAF9CE77-5619-445A-8508-222465BEF058

P478

Q38152292-6190754E-47D9-4BF4-9721-F46434E40AA0

P50

Q38152292-021F0C46-DB58-4732-8F88-8BF00A888145

Q38152292-2FA661D5-0607-4A13-AA24-2308E4548CFE

P577

Q38152292-39CA1320-CC9B-4DCA-86CA-D5A431B16241

P6179

Q38152292-2A1A9EB1-8D1B-4A2A-8E5A-F60670CA1D0B

P698

Q38152292-60ADAD08-742E-4739-BB2A-A9006F3C61DA

P921

Q38152292-1E1DBA16-2949-4D82-9423-C1DD957A268D

Q38152292-47956061-1305-4942-8F34-300C36A41BB2

P356

S11906-013-0394-8

P1433

Current Hypertension Reports

P1476

An update on medical therapy for pulmonary arterial hypertension.

@en

P2093

Yan Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Treprostinil for the treatment of pulmonary arterial hypertension

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Inhaled iloprost for severe pulmonary hypertension.

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.

Riociguat for the treatment of pulmonary arterial hypertension.

Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.

Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension.

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.

P2888

s11906-013-0394-8

P304

614-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-013-0394-8

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

D S O'Callaghan

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024664858

http://www.w3.org/2001/XMLSchema#string

P698

24122306

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension